LONG-TERM EFFICACY AND SAFETY OF LOW DOSE AND DOSE ESCALATING INTERFERON ALFA-2A THERAPY IN REFRACTORY BEHCET'S UVEITIS

被引:0
|
作者
Onal, Sumru [1 ]
Kazokoglu, Haluk [1 ]
Koc, Aylin [1 ]
Akman, Mehmet
Bavbek, Tayfun [1 ]
Direskenell, Haner [2 ]
Yavuz, Sule [2 ]
机构
[1] Univ Marmara, Dept Ophthalmol, Istanbul, Turkey
[2] Univ Marmara, Dept Rheumatol, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S147 / S147
页数:1
相关论文
共 50 条
  • [41] Interferon alfa-2a: A new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study
    Deuter, Christoph M. E.
    Koetter, Ina
    Guenaydin, Ilhan
    Stuebiger, Nicole
    Zierhut, Manfred
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (07): : 786 - 791
  • [42] Low dose peginterferon alfa-2a and ribavirin for chronic hepatitis C, genotype 2 & 3: Viral kinetics, efficacy and safety
    Rotman, Yaron
    Borg, Brian B.
    Soza, Alejandro
    Loomba, Rohit
    Modi, Apurva A.
    Feld, Jordan J.
    Rivera, Elenito
    Doo, Edward
    Heller, Theo
    Ghany, Marc
    Neumann, Avidan U.
    Liang, T. Jake
    Hoofnagle, Jay H.
    HEPATOLOGY, 2007, 46 (04) : 383A - 383A
  • [43] LOW-DOSE VERSUS HIGH-DOSE INTERFERON ALFA-2A IN RELAPSED INDOLENT NON-HODGKINS-LYMPHOMA
    VANDERMOLEN, LA
    STEIS, RG
    DUFFEY, PL
    FOON, KA
    SMITH, JW
    CLARK, JW
    CONLON, K
    STEVENSON, HC
    URBA, WJ
    HARTMANN, LC
    WATSON, T
    JAFFE, ES
    LONGO, DL
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (03): : 235 - 238
  • [44] Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis
    Sarzi-Puttini, P
    Cazzola, M
    Panni, B
    Turiel, M
    Fiorini, T
    Belai-Beyene, N
    Chèrié-Lignièré, EL
    RHEUMATOLOGY INTERNATIONAL, 2002, 21 (06) : 234 - 238
  • [45] Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis
    Piercarlo Sarzi-Puttini
    Marco Cazzola
    Benedetta Panni
    Maurizio Turiel
    Tania Fiorini
    Nebiat Belai-Beyene
    Enrico Chèrié-Lignièré
    Rheumatology International, 2002, 21 : 234 - 238
  • [46] Efficacy and safety of long-term, low-dose isotretinoin for treatment of acne vulgaris
    Taghipour, K.
    James, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 : 42 - 43
  • [47] LONG-TERM EFFICACY AND SAFETY OF LOW-DOSE REGIMEN OF AMIODARONE FOR VENTRICULAR ARRHYTHMIAS
    KERIN, NZ
    BLEVINS, R
    FAITEL, K
    MACIEJKO, J
    RUBENFIRE, M
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1987, 10 (04): : 1000 - 1000
  • [48] Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behcet's disease
    Ueda, Sho
    Akahoshi, Mitsuteru
    Takeda, Atsunobu
    Inoue, Yasushi
    Omoto, Aya
    Ayano, Masahiro
    Kimoto, Yasutaka
    Mitoma, Hiroki
    Arinobu, Yojiro
    Niiro, Hiroaki
    Tsukamoto, Hiroshi
    Horiuchi, Takahiko
    Hikita, Shin-Ichi
    Fukuhara, Takako
    Ishibashi, Tatsuro
    Sonoda, Koh-Hei
    Akashi, Koichi
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (01) : 9 - 15
  • [49] LOW-DOSE RECOMBINANT INTERFERON ALFA-2A TREATMENT FOR CLASSIC KAPOSIS-SARCOMA - REPLY
    TUR, E
    BRENNER, S
    ARCHIVES OF DERMATOLOGY, 1994, 130 (06) : 800 - 801
  • [50] Long-Term Efficacy and Safety of Infliximab in the Treatment of Behcet's Disease
    Capella, Maria Jose
    Foster, C. Stephen
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2012, 20 (03) : 198 - 202